2007
DOI: 10.1016/j.tips.2006.12.006
|View full text |Cite|
|
Sign up to set email alerts
|

Ca2+ channel α2δ ligands: novel modulators of neurotransmission

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
218
1
4

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 355 publications
(227 citation statements)
references
References 55 publications
4
218
1
4
Order By: Relevance
“…The interaction between α2δ subunits of voltage-gated Ca 2+ channel and the drugs explains the mechanism of action for their therapeutic effects for several clinical disorders, including epilepsy, pain from diabetic neuropathy, postherpetic neuralgia and fibromyalgia, and generalized anxiety disorder (Dooley et al, 2007). Gabapentin also inhibits the plasma membrane trafficking of β 4a-bound Ca v 2.1 complexes according to a recent report (Mich and Horne, 2008).…”
Section: Discussionmentioning
confidence: 97%
“…The interaction between α2δ subunits of voltage-gated Ca 2+ channel and the drugs explains the mechanism of action for their therapeutic effects for several clinical disorders, including epilepsy, pain from diabetic neuropathy, postherpetic neuralgia and fibromyalgia, and generalized anxiety disorder (Dooley et al, 2007). Gabapentin also inhibits the plasma membrane trafficking of β 4a-bound Ca v 2.1 complexes according to a recent report (Mich and Horne, 2008).…”
Section: Discussionmentioning
confidence: 97%
“…Eight of our 10 patients used either gabapentin or pregabalin, which act on voltage-sensitive calcium channels (37). In anesthetized rats, gabapentin modulates the BOLD signal in several areas involved in nociceptive processing, for example, by increasing activity in thalamus and periaqueductal gray matter and decreasing it in amygdala (38).…”
Section: Discussionmentioning
confidence: 99%
“…channel (VGCC) in the CNS [21][22][23]. They inhibit presynaptic neurotransmitter release from hyperexcitable or abnormal neurons by blocking trafficking of the a 2 d-1 subunit to the presynaptic membrane [24][25][26][27]. Experimentally, expression of a 2 d-1, but not a 2 d-2 (another binding site of GBP), is significantly increased in both the dorsal root ganglia (DRG) and the dorsal horn of the spinal cord in animal models of peripheral neuropathic pain.…”
Section: Introductionmentioning
confidence: 99%